Activated cyanoacetamide in heterocyclic synthesis: Design, synthesis, antitumor activity and docking study of some new pyrimidine derivatives
作者:Dalia R. Emam、Nanees N. Soliman、Ahmed A. Fadda、Nesma M. Bayoumy
DOI:10.1016/j.molstruc.2023.137009
日期:2024.2
All the newly synthesized compounds were characterized with spectroscopic analyses. Compounds were tested for their anticancer activity against three human cancer cell lines: hepatocellular carcinoma (HepG-2), colon cancer (HCT-116), and mammary gland breast cancer (MCF-7). The studied compound's cytotoxic activity ranged from very strong to very weak. The most active compounds were 9, 10, 11, 27, and
前体氰基乙酰胺衍生物(6)是由嘧啶衍生物5与氰乙酸在乙酐催化下反应得到的。氰基乙酰胺衍生物6与不同试剂反应得到许多杂环体系,如硫代乙酸(9)、二硫杂环戊烷衍生物(11)和(12)、1,8-萘啶(14)、喹啉衍生物(17)和(18),吡啶衍生物20、22、24、26和27、哒嗪(30)、吡喃并嘧啶(32)和吡唑并嘧啶(34)。所有新合成的化合物均通过光谱分析进行表征。测试了化合物对三种人类癌细胞系的抗癌活性:肝细胞癌 (HepG-2)、结肠癌 (HCT-116) 和乳腺乳腺癌 (MCF-7)。所研究的化合物的细胞毒活性范围从非常强到非常弱。最活跃的化合物是9、10、11、27和34。使用分子对接(PDB = 4EJN)研究了对接化合物(特别是9、10、11、27和34 )对与共结晶配体复合的AKT的结合位点的结合处置。